<DOC>
	<DOCNO>NCT00146289</DOCNO>
	<brief_summary>The primary objective study determine whether MICARDIS® improve insulin sensitivity overweight obese , non-diabetic , normotensive subject .</brief_summary>
	<brief_title>The Primary Objective This Study Determine Whether MICARDIS® Improves Insulin Sensitivity Overweight Obese , Non-diabetic , Normotensive Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Ability provide write informed consent accordance Good Clinical Practice ( GCP ) local legislation . 2 . Subjects 1865 year old . 3 . Body Mass Index ( BMI ) &gt; = 28 . 4 . Sedentary life style define : Does engage vigorous activity 30 minute per day , two time per week . 5 . Waist circumference &gt; = 40 inch ( 102 cm ) men &gt; = 35 inch ( 89 cm ) woman . 6 . HbA1C assess &lt; = 6.5 % . 7 . Triglycerides &gt; = 150 , &lt; = 500 mg/dL . 8 . Fasting Glucose &lt; = 126 mg/dL . 9 . Blood pressure &gt; = 110/64 &lt; = 140/90 mmHg . 1 . Currently take antihypertensive medication ( e.g. , thiazide loop diuretic ) , diabetic medication , medication know alter insulin sensitivity ( e.g. , statin ) , steroid , glucocorticoid , niacin , nicotinic acid , antipsychotic/depressant drug ( e.g. , prozocin ) . Including counter ( OTC ) herbal product , know affect metabolic function . 2 . Diagnosis follow chronic disease : hypertension , diabetes mellitus , renal insufficiency , congestive heart failure , hepatic insufficiency , biliary obstructive disorder , autoimmune disease , HIV , coronary artery disease , mental illness , severe anemia . 3 . Sustained ventricular tachycardia , atrial fibrillation , atrial flutter clinically relevant cardiac arrhythmia determine investigator . 4 . Hypertrophic obstructive cardiomyopathy , aortic stenosis , hemodynamically relevant stenosis aortic mitral valve . 5 . Unstable angina myocardial infarction cardiac surgery within past 3 month . 6 . PCI ( percutaneous coronary intervention ) within past 3 month . 7 . Stroke within past 6 month . 8 . Bilateral renal artery stenosis obstructive disorder , renal artery stenosis solitary kidney , postrenal transplant patient patient one kidney . 9 . Hepatic and/or renal dysfunction define follow laboratory parameter : SGPT ( ALT ) SGOT ( AST ) &gt; 2.5 time upper limit normal range , Serum creatinine &gt; 2.3 mg/dL ( &gt; 203 mol/L ) 10 . Premenopausal woman ( last menstruation &lt; =1 year prior sign informed consent ) : Have positive urine pregnancy test ( UPT ) prior randomisation ( Visit 2 Visit 2.1 subject participate clamp procedure ) Are surgically sterile , Are nursing , pregnant , Are childbearing potential NOT practice acceptable method birth control , NOT plan continue practice acceptable method throughout study agree periodic pregnancy test participation study . Acceptable method birth control limit : IntraUterine Device ( IUD ) , oral , implantable injectable contraceptive estrogen patch . No exception make . 11 . Hematocrit &lt; 35 % . 12 . Primary aldosteronism . 13 . Hereditary fructose intolerance . 14 . History drug alcohol dependency within previous 6 month . 15 . Currently participate weight loss program . 16 . Any investigational drug therapy within one month randomisation study . 17 . Known hypersensitivity component study drug ( telmisartan placebo ) . 18 . Any circumstance Investigator feel participation study would hinder subject safety completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>